Custom Protein Generation

Drug Substance Manufacture

Drug Product Fill & Finish

Development

Testing

Discovery

Antibody Drug Conjugates

Technologies & Platforms

Latest News

2019/03/20
WuXi Biologics Receives EMA GMP Certificates

2019/03/18
WuXi Biologics Continues to Deliver Record Results

2019/02/28
WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA

2019/02/26
ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Novel Immune Check Point Bispecifics for $220 Million

2019/02/19
EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo™ at WuXi Biologics

2019/02/12
WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

2018/12/19
WuXi Biologics and AC Immune to Establish an Exclusive Strategic Partnership

2018/12/13
WuXi Biologics Congratulates Tychan on First-in-Class Monoclonal Antibody for Yellow Fever after Record 7 Months of Development

2018/12/12
WuXi Biologics Achieves Breakthrough Titer of 51g/L in Cell Culture Productivity

2018/12/11
Oxford BioTherapeutics Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Five Bispecific Antibody Programs for up to $450 Million

2018/12/10
WuXi Biologics Announced Exclusive Discovery Research with Brii Biosciences for Novel Bispecific Antibody Immunotherapeutics

2018/12/06
WuXi Biologics Wins SCRIP Award for “Best Company in an Emerging Market”

2018/12/05
WuXi Biologics Commenced Construction of the Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland

 

See below for other press releases by year.

2018  2017  2016  2015  2014  2013  2012


 

Upcoming Events

CPhI Japan

March 18-20, 2019 | Tokyo, Japan

Meet us at the event

DCAT Week

March 18-21, 2019 | New York, NY

Meet us at the event

BIO-Europe Spring

March 25-27, 2019 | Vienna, Austria

Meet us at the event

CHI PEGS

April 8-12, 2019 | Boston, MA

Meet us at the event

 

BACK